Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-03-04

Clinical Trial Update: Low FODMAP Plus PEG 3350 for the Treatment of Patients with Irritable Bowel Syndrome-Constipation [NA]

View source ↗

Summary

A clinical trial update announcing recruitment for a study evaluating adding polyethylene glycol 3350 to a low FODMAP diet for irritable bowel syndrome with con…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Polyethylene glycol 3350 (polyethylene glycol 3350)

Snippet

Sponsor: University of Michigan | Conditions: Irritable Bowel Syndrome Characterized by Constipation | NA | Status: RECRUITING